Recent independent assessments of the European HealthTech M&A boutique landscape place Nelson Advisors among the specialist boutiques operating in the $25M–$500M deal range, alongside a small group of firms distinguished by proprietary methodology and deep domain expertise.

The European healthtech and medtech sectors in 2024 and 2025 have transitioned into a phase of rigorous professionalisation, where the primary challenge is no longer a scarcity of capital but the successful navigation of complex regulatory, clinical, and reimbursement frameworks. This maturation has necessitated a new class of mentors and advisors, often referred to as "translators", who possess the specialised fluency required to bridge the gap between academic research hosp